Piramal Enterprises

₹819.9 2.9 | 0.4%

WEBSITE BSE:500302 NSE : PEL 23 May, 11:18

Market Cap ₹18420 Cr.

Stock P/E -10.8

P/B 0.9

Current Price ₹819.9

Book Value ₹ 961.1

Face Value 2

52W High ₹1140

Dividend Yield 1.22%

52W Low ₹ 757.3

Edit Ratio

Piramal Enterprises Research see more...

Overview Inc. Year: 1947Industry: Finance - NBFC

Piramal Enterprises Limited (PEL) is an India-based company this is engaged in various business, consisting of financial services and pharmaceuticals. PEL's monetary services offer various financial products and solutions, with wholesale and retail financing. The wholesale lending business gives financing to real estate builders, in addition to corporate. Within retail lending, PEL is engaged in constructing a multi-product platform and offers domestic loans, loans for small organizations and loans for working capital to its clients. The Company offers India Resurgence Fund (IndiaRF), the distressed asset investment platform, which invests in equity and/or debt across non-real estate sectors. Its monetary offerings additionally encompass opportunity belongings and investments in Shriram Group. PEL has a differentiated enterprise model this is different across three segments: Contract Development and Manufacturing Organization (CDMO), Complex Hospital Generics (CHG), and India Consumer Healthcare.

Piramal Enterprises Share Price

New

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

Piramal Enterprises Quarterly Results

#(Fig in Cr.)
Net Sales
Other Income
Total Income
Total Expenditure
Operating Profit
Interest
Depreciation
Exceptional Income / Expenses
Profit Before Tax
Provision for Tax
Profit After Tax
Adjustments
Profit After Adjustments
Adjusted Earnings Per Share

Piramal Enterprises Profit & Loss

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Net Sales	1401	1991	2401	3424	3809	3297	3671	2013	1825	2719	4785
Other Income	395	293	299	472	581	642	472	742	286	130	162
Total Income	1796	2284	2700	3896	4390	3939	4142	2755	2111	2848	4947
Total Expenditure	1546	1783	1957	2116	2197	2085	2024	727	820	396	1813
Operating Profit	250	501	743	1780	2193	1855	2119	2028	1291	2453	3133
Interest	420	813	307	787	1178	990	1497	1710	1069	1243	712
Depreciation	78	76	89	80	94	112	131	42	33	22	23
Exceptional Income / Expenses	0	18	299	70	0	0	-1288	0	-258	-10	11912
Profit Before Tax	-248	-370	646	984	920	753	-798	276	-69	1177	14311
Provision for Tax	-16	0	274	-12	143	235	70	390	51	213	-22
Profit After Tax	-232	-370	373	996	777	518	-868	-115	-120	964	14333
Adjustments	0	0	0	0	0	0	0	260	160	33	0
Profit After Adjustments	-232	-370	373	996	777	518	-868	145	40	998	14333
Adjusted Earnings Per Share	-13	-20.8	21	56	43.7	28.1	-45.9	-5.1	-5.3	40.4	600.6

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	76%	33%	8%	13%
Operating Profit CAGR	28%	16%	11%	29%
PAT CAGR	1387%	0%	94%	0%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	6%	-22%	-17%	3%
ROE Average	60%	21%	12%	7%
ROCE Average	46%	19%	13%	9%

Piramal Enterprises Balance Sheet

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Shareholder's Funds	10556	9127	11447	12801	14423	21337	19492	22628	23184	24086	24034
Minority's Interest	0	0	0	0	0	0	0	0	0	0	0
Borrowings	733	653	1195	5633	2740	4012	4620	2390	3386	5710	6402
Other Non-Current Liabilities	413	3866	3852	4017	4150	4487	4600	4627	-5	4947	4894
Total Current Liabilities	8567	7069	4122	8792	8428	11427	13786	9636	4403	3926	2937
Total Liabilities	20269	20715	20616	31243	29740	41262	42498	39280	30967	38668	38268
Fixed Assets	773	780	756	954	1075	1807	1824	1789	91	99	30
Other Non-Current Assets	11907	16265	14336	26771	24621	34446	37705	34370	27352	23517	19397
Total Current Assets	7589	3670	5524	3517	4045	5009	2969	3121	3525	15053	16563
Total Assets	20269	20715	20616	31243	29740	41262	42498	39280	30967	38668	38268

Piramal Enterprises Cash Flow

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Opening Cash & Cash Equivalents	8	17	23	-18	-33	82	460	-54	-1577	1342	1402
Cash Flow from Operating Activities	-1752	-1749	-3369	-7131	-6348	-4910	6747	1134	2257	3106	917
Cash Flow from Investing Activities	-791	1638	6750	-1440	-2424	-4403	-9329	1887	2679	-27	-37
Cash Flow from Financing Activities	2552	87	-3398	8556	8887	9690	2069	-4544	-2466	-3011	-604
Net Cash Inflow / Outflow	9	-24	-17	-15	115	376	-513	-1523	2470	68	276
Closing Cash & Cash Equivalent	17	23	27	-33	82	458	-54	-1577	893	1410	1678

Piramal Enterprises Ratios

#	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Earnings Per Share (Rs)	-13.02	-20.81	20.97	56.01	43.69	28.08	-45.94	-5.09	-5.33	40.4	600.6
CEPS(Rs)	-8.65	-16.52	25.96	60.48	49.01	34.12	-39	-3.23	-3.87	41.33	601.56
DPS(Rs)	17.5	52.5	20	17.5	21	25	28	14	33	33	31
Book NAV/Share(Rs)	593.75	513.38	643.87	720.02	811.25	1155.61	1031.43	1003.24	1027.88	1009.24	1007.1
Core EBITDA Margin(%)	-10.34	10.43	18.52	38.2	42.32	36.77	44.87	63.87	55.06	85.45	62.11
EBIT Margin(%)	12.28	22.23	39.7	51.7	55.08	52.87	19.06	98.65	54.78	89.04	313.94
Pre Tax Margin(%)	-17.69	-18.59	26.92	28.73	24.15	22.85	-21.73	13.69	-3.79	43.3	299.06
PAT Margin (%)	-16.52	-18.59	15.52	29.08	20.39	15.73	-23.65	-5.7	-6.59	35.47	299.53
Cash Profit Margin (%)	-10.97	-14.76	19.22	31.4	22.87	19.11	-20.07	-3.62	-4.79	36.28	300.01
ROA(%)	-1.22	-1.81	1.8	3.84	2.55	1.46	-2.07	-0.28	-0.34	2.77	37.26
ROE(%)	-2.13	-3.76	3.62	8.21	5.71	2.9	-4.25	-0.54	-0.52	4.08	59.57
ROCE(%)	1.24	2.93	6.29	8.5	8.22	5.75	1.92	5.66	3.17	7.77	46.08
Receivable days	63.23	45.78	44.37	39.02	42.93	54.49	55.14	115.44	81.23	20.2	0
Inventory Days	68.82	51.55	47.24	37.11	34.41	40.17	37.06	71.3	52.57	21.12	0
Payable days	163.96	139.7	108.6	157.29	199.21	221.92	237.19	2050.67	438.74	0	0
PER(x)	0	0	40.23	17.95	42.25	84.85	0	0	0	54.13	1.13
Price/Book(x)	1	1.03	1.31	1.4	2.28	2.06	2.61	0.94	1.7	2.17	0.67
Dividend Yield(%)	2.87	9.64	2.3	1.69	1.1	1.02	1.02	1.49	1.88	1.51	4.57
EV/Net Sales(x)	10.81	7.67	7.84	9.17	11.28	17.6	18.59	15.73	24.78	21.72	4.81
EV/Core EBITDA(x)	60.64	30.48	25.32	17.64	19.59	31.29	32.2	15.62	35.04	24.07	7.34
Net Sales Growth(%)	21.49	42.05	20.64	42.6	11.24	-13.45	11.34	-45.17	-9.35	48.99	76.02
EBIT Growth(%)	-46.41	157.18	115.39	85.73	18.51	-16.93	-59.86	183.81	-49.66	142.17	520.62
PAT Growth(%)	-277.14	-59.79	200.74	167.13	-21.99	-33.25	-267.42	86.78	-4.76	902.03	1386.55
EPS Growth(%)	-277.14	-59.79	200.74	167.13	-21.99	-35.73	-263.61	88.93	-4.76	858	1386.55
Debt/Equity(x)	0.44	0.65	0.34	1.06	0.71	0.68	0.9	0.47	0.29	0.35	0.36
Current Ratio(x)	0.89	0.52	1.34	0.4	0.48	0.44	0.22	0.32	0.8	3.83	5.64
Quick Ratio(x)	0.86	0.48	1.26	0.36	0.44	0.4	0.19	0.28	0.78	3.78	5.64
Interest Cover(x)	0.41	0.54	3.11	2.25	1.78	1.76	0.47	1.16	0.94	1.95	21.11
Total Debt/Mcap(x)	0.44	0.63	0.26	0.76	0.31	0.33	0.34	0.5	0.17	0.16	0.54

Piramal Enterprises Shareholding Pattern

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	43.49	43.49	43.49	43.48	43.48	43.48	43.48	46.19	46.19	46.19
FII	35.31	35.03	34.54	32.06	31.25	28.67	26.05	19.68	17.18	16.97
DII	8.19	8.44	8.14	7.86	8.06	9.59	11.92	12.05	13.02	13.19
Public	13	13.03	13.84	16.6	17.2	18.25	18.55	22.07	23.6	23.64
Others	0	0	0	0	0	0	0	0	0	0
Total	100	100	100	100	100	100	100	100	100	100

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	10.38	10.38	10.38	10.38	10.38	10.38	10.38	10.38	10.38	10.38
FII	8.43	8.36	8.24	7.65	7.46	6.84	6.22	4.42	3.86	3.81
DII	1.96	2.01	1.94	1.88	1.92	2.29	2.85	2.71	2.93	2.96
Public	3.1	3.11	3.3	3.96	4.11	4.36	4.43	4.96	5.3	5.31
Others	0	0	0	0	0	0	0	0	0	0
Total	23.87	23.87	23.87	23.87	23.87	23.87	23.87	22.47	22.47	22.47

Pros

Stock is trading at 0.9 times its book value
Company has delivered good profit growth of 94% CAGR over last 5 years
Company has a good return on equity (ROE) track record: 3 Years ROE 21%

Cons

Promoter holding is low: 46.19%.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.